Findings

What do systematic reviews say?

4 questions · 4 findings · 1 reviews · Skin

No studies found 1 · 25%GRADE not reported 0 · 0%Very low 3 · 75%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

All‐cause mortality · NSTI

It is very uncertain whether moxifloxacin changes mortality compared with amoxicillin‐clavulanate (very low certainty).

1 finding from 1 review

Interventions for necrotizing soft tissue infections in adults 2018 · Cochrane Headline outcomes only
RR 3 [0.39, 23.07]
1 study · 54 participants
Very low

SAEs · NSTI

It is very uncertain whether moxifloxacin changes serious adverse events (SAE) compared with amoxicillin‐clavulanate (very low certainty).

1 finding from 1 review

Interventions for necrotizing soft tissue infections in adults 2018 · Cochrane Headline outcomes only
RR 0.63 [0.3, 1.31]
1 study · 54 participants
Very low

Survival time · NSTI

1 finding from 1 review

Interventions for necrotizing soft tissue infections in adults 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 54 participants
Very low

Assessment of long‐term morbidity · NSTI

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for necrotizing soft tissue infections in adults 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found